Determination of imipenem in plasma by high-performance liquid chromatography for pharmacokinetic studies in patients.
A rapid and simple HPLC method is described for the determination of imipenem in human plasma. After blood collection, plasma was separated by centrifugation and immediately stabilized with 3-morpholinopropanesulfonic acid (MOPS) and ethylene glycol solution (1:1). The sample preparation, before injection into HPLC, was ultrafiltration. The mobile phase was boric acid buffer. The imipenem was detected at 300 nm and cilastatin sodium, coadministered, did not interfere. Calibration curves in human plasma were linear from 0.1 to 100 microg/ml. The limit of detection was 0.030 microg/ml. Inter-day precision at 0.1 microg/ml, determined as the coefficient of variation, was 6.26%. Only 250 microl of plasma was required in our assay. Due to the limited stability of imipenem [G.B. Smith et al., J. Pharm. Sci., 79 (1990) 732], stability studies in plasma were done to establish appropriate storage conditions. The assay was applied to pharmacokinetic studies in patients.
Garcia-Capdevila
L
L
Hospital Sta. Crue i St. Pau, Pharmacy Department, Barcelona, Spain.
López-Calull
C
C
Arroyo
C
C
Moral
M A
MA
Mangues
M A
MA
Bonal
J
J
D002851:Chromatography, High Pressure Liquid; D004355:Drug Stability; D006801:Humans; D015378:Imipenem / Q000097:blood* / Q000493:pharmacokinetics; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity; D013845:Thienamycins / Q000097:blood* / Q000493:pharmacokinetics; D014462:Ultrafiltration
D013845:Thienamycins; D015378:Imipenem